Pentoxifylline and Endometriosis

To prove efficacy of an immunomodulator called pentoxifylline in the treatment of endometriosis in infertile patients undergoing laparoscopy surgery

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Endometriosis-Associated Infertility Endometriosis Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Genital Diseases Genital Diseases, Female Infertility Urogenital Diseases

Age range

18 year–40 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 3

Primary location

Hospital Clinic

Barcelona, 08036, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Infertile patients having early endometriosis as the only factor of their infertility

Exclusion criteria

Previous treatment for endometriosis or patients having pelvic disorders in addition to endometriosis

Treatment and study plan

Pentoxifylline

Drug

800 mg daily for six months

Placebo

Drug

Primary outcomes

Pregnancy rate

Time frame: 6 months follow-up

Sponsors and collaborators

Lead sponsor

Hospital Clinic of Barcelona

Other

Registry information

Official study title

Combined Laparoscopic Surgery and Pentoxifylline Therapy for Treatment of Endometriosis-Associated Infertility: A Preliminary Study

Acronym: LETS1

Important dates

Study start: 2001
Primary completion: 2006
Study completion: 2006
First posted: Mar 11, 2008
Registry last updated: Mar 11, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed